Qualitative Study on Diversity, Equity, and Inclusion Within Radiation Oncology in Europe.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 06 2023
Historique:
received: 08 09 2022
revised: 23 01 2023
accepted: 03 02 2023
medline: 15 5 2023
pubmed: 16 2 2023
entrez: 15 2 2023
Statut: ppublish

Résumé

Organizational culture plays a major role in prioritizing diversity, equity, and inclusion (DEI) objectives by aligning individual values of employees with organizational values. However, effective strategies to create an inclusive organizational culture, in which these values are aligned, remain unclear. The European Society for Radiotherapy and Oncology (ESTRO) launched a qualitative study, as a follow-up of the previous project on DEI that highlighted low levels of inclusion and work engagement among radiation oncology (RO) professionals in Europe. The aim of the present study was to gain an understanding of how DEI could be improved within RO departments by creating a more inclusive organizational culture. A qualitative research study was conducted by enrolling RO professionals from 4 selected European countries through an open call on the ESTRO platform. Respondents who completed an online survey and met the inclusion criteria, such as experiencing low DEI levels at work, were invited for an online semistructured interview. Interview transcripts were analyzed thematically with an abductive approach via concepts in relation to "DEI," "work engagement," "organizational culture," and "professional values." Twenty-six eligible respondents from Great Britain, Italy, Poland, and Switzerland were interviewed. The thematic analysis identified cases in which limited engagement at work emerged when the personal values of RO professionals conflicted with dominant organizational values, hampering DEI. Three conflicts were found between the following personal versus organizational values: (1) self-development versus efficiency, (2) togetherness versus competition, and (3) people-oriented versus task-oriented cultures. Awareness of how organizational values can conflict with professionals' values should be raised to improve inclusion and engagement in the workplace. Additionally, efforts should be focused on tackling existing power imbalances that hamper effective deliberation on organizational- versus personal-value conflicts.

Identifiants

pubmed: 36792016
pii: S0360-3016(23)00151-7
doi: 10.1016/j.ijrobp.2023.02.009
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

246-256

Subventions

Organisme : Cancer Research UK
ID : C1994/A28701
Pays : United Kingdom

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Azadeh Abravan (A)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom; Department of Radiotherapy Related Research, Christie National Health Service (NHS) Foundation Trust, Manchester, United Kingdom.

Dora Correia (D)

Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland; Department of Radiation Oncology, Cantonal Hospital Aarau, Aarau, Switzerland. Electronic address: dora.correia@ksa.ch.

Anne Gasnier (A)

Radiotherapy Department, Gustave Roussy Cancer Campus, Villejuif, France.

Stella Shakhverdian (S)

Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

Tirza van der Stok (T)

Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

Jenny Bertholet (J)

European Society for Radiotherapy and Oncology (ESTRO) Young Committee, Brussels, Belgium; Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Switzerland.

Ludwig J Dubois (LJ)

European Society for Radiotherapy and Oncology (ESTRO) Young Committee, Brussels, Belgium; The M-Lab, Department of Precision Medicine, GROW - School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.

Barbara Alicja Jereczek-Fossa (BA)

Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy; European Society for Radiotherapy and Oncology (ESTRO) National Societies Committee, Brussels, Belgium.

Matteo Pepa Eng (MP)

Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Mateusz Spalek (M)

European Society for Radiotherapy and Oncology (ESTRO) Young Committee, Brussels, Belgium; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

Steven F Petit (SF)

European Society for Radiotherapy and Oncology (ESTRO) Young Committee, Brussels, Belgium; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Pierfrancesco Franco (P)

European Society for Radiotherapy and Oncology (ESTRO) Young Committee, Brussels, Belgium; Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.

Violet Petit-Steeghs (V)

Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH